The world's scientific and social network for malaria professionals
Subscribe to free Newsletter | 10493 malaria professionals are enjoying the free benefits of MalariaWorld today

united states

Barriers to malaria prevention among immigrant travelers in the United States who visit friends and relatives in sub-Saharan Africa: A cross-sectional, multi-setting survey of knowledge, attitudes, and practices

March 18, 2020 - 14:24 -- Open Access
Author(s): 
Volkman HR, Walz EJ, Stauffer WM, et al.
Reference: 
PLoS One. 2020 Mar 12;15(3):e0229565

Despite achievements in the reduction of malaria globally, imported malaria cases to the United States by returning international travelers continue to increase. Immigrants to the United States from sub-Saharan Africa (SSA) who then travel back to their homelands to visit friends and relatives (VFRs) experience a disproportionate burden of malaria illness. Various studies have explored barriers to malaria prevention among VFRs and non-VFRs–travelers to the same destinations with other purpose for travel–but few employed robust epidemiologic study designs or performed comparative analyses of these two groups. To better quantify the key barriers that VFRs face to implement effective malaria prevention measures, we conducted a comprehensive community-based, cross-sectional, survey to identify differences in malaria prevention knowledge, attitudes, and practices (KAP) among VFRs and others traveling to Africa and describe the differences between VFRs and other types of international travelers.

NOT Open Access | Treatment of Severe Malaria in the United States

February 17, 2020 - 12:22 -- NOT Open Access
Author(s): 
John CC
Reference: 
Ann Intern Med. 2020 Feb 4;172(3):224-225

The American Society of Tropical Medicine and Hygiene (ASTMH) shares Krey and Travassos' (1) concerns about treatment of severe malaria in the United States.

Guidance for Using Tafenoquine for Prevention and Antirelapse Therapy for Malaria - United States, 2019

November 30, 2019 - 20:08 -- Open Access
Author(s): 
Haston JC, Hwang J, Tan KR.
Reference: 
MMWR Morb Mortal Wkly Rep. 2019 Nov 22;68(46):1062-1068.

This report summarizes the published efficacy and safety evidence for the recommended doses for both indications and provides guidance for the use of tafenoquine in the United States. A more comprehensive review of the literature on tafenoquine along with the biologic rationale for its use has been published elsewhere (10).

Subscribe to RSS - united states